Daewoong Pharmaceutical Co., Ltd (KRX:069620)

South Korea · Delayed Price · Currency is KRW

149,800

+500 (0.33%)

At close: Apr 8, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing and Sales of Pharmaceuticals			1.41T	1.32T	1.18T	1.08T	1.15T
Manufacturing and Sales of Pharmaceuticals Growth			7.06%	11.17%	9.68%	-6.50%	8.93%
Service Provision			23.65B	9.84B	7.80B	6.14B	8.12B
Service Provision Growth			140.29%	26.22%	26.90%	-24.36%	35.00%
Other			8.26B	5.23B	1.47B	1.54B	1.31B
Other Growth			57.92%	257.10%	-4.88%	17.49%	110.39%
Consolidation			-66.10B	-51.58B	-40.58B	-32.07B	-50.93B
Total			1.38T	1.28T	1.15T	1.06T	1.11T
Total Growth			7.44%	11.03%	9.24%	-5.21%	7.95%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Export			212.15B	184.96B	117.89B	92.92B	-
Export Growth			14.70%	56.89%	26.87%	-	-
South Korea			1.23T	1.15T	1.08T	994.57B	-
South Korea Growth			7.20%	6.61%	8.15%	-	-
Consolidation			-66.10B	-51.58B	-40.58B	-32.07B	-
Total			1.38T	1.28T	1.15T	1.06T	-
Total Growth			7.44%	11.03%	9.24%	-	-

Source: S&P Global Market Intelligence.